Medication Review Focusing on Anticoagulation Therapy in Swiss Community Pharmacies

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2016

Study Completion Date

December 31, 2016

Conditions
Drug Therapy Management
Interventions
BEHAVIORAL

Extended polymedication check

"Behavioral: Medication review~Patients on oral anticoagulants and polypharmacy will receive extended polymedication check to identify Pharmaceutical Care Issues, Adherence Issues, Drug related problems and Knowledge Gaps~The PMC has been implemented in 2010 as a new cognitive service provided by any community pharmacist to patient with polypharmacy (n\>3 drugs) on long term conditions (\> 3 months) and is reimbursed by swiss health insurance. The semi-structured interview contains questions about knowledge on oral anticoagulation therapy. This extended PMC follows a structured predefined protocol.~As an outcome, pharmacist may install a compliance support e.g. weekly filled pill organizer."

Trial Locations (1)

4056

Pharmaceutical Care Research Group University of Basel, Basel

All Listed Sponsors
collaborator

University of Basel

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT02703727 - Medication Review Focusing on Anticoagulation Therapy in Swiss Community Pharmacies | Biotech Hunter | Biotech Hunter